DaVita Inc.

NYSE DVA

DaVita Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2024: 12.68%

DaVita Inc. Return on Capital Employed (ROCE) is 12.68% for the Trailing 12 Months (TTM) ending September 30, 2024, a 25.52% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

DaVita Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 10.10%, a 2.45% change year over year.
DaVita Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2022 was 9.86%, a -15.54% change year over year.
DaVita Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 11.67%, a -2.78% change year over year.
DaVita Inc. Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending September 30, 2020 was 12.01%, a 3.75% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NYSE: DVA

DaVita Inc.

CEO	Mr. Javier J. Rodriguez
IPO Date	Oct. 31, 1995
Location	United States
Headquarters	2000 16th Street
Employees	70,000
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals Telehealth

Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Key trends

Past 5 years